Journals / Çocuk Dergisi / 2008 / Cilt: 8 - Sayı: 2

Insulin resistance in preterm born children during prepubertal ages

Preterm doğan çocuklarda prepubertal dönemde insülin direncinin değerlendirilmesi

Pages
87–92
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The similar insulin levels in preterm SGA and preterm AGA children together with increased insulin levels in term SGA children points to the fact that it is the intrauterine restriction in the third trimester that has an adverse effect on future adverse metabolic outcome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Aim of this study was to evaluate insulin resistance in preterm born children born appropriate for gestational age (AGA) or small for gestational age (SGA).
📊
Key Findings & Data:Material and Methods: Ninety-three preterm born children grouped as premature SGA (n=30) and premature AGA (n=63) were evaluated at age 4.6±0.2 years and 4.7±0.1 years with respect to their glucose, insulin and IGFBP-1 levels.
💡
Conclusion & Impact:The similar insulin levels in preterm SGA and preterm AGA children together with increased insulin levels in term SGA children points to the fact that it is the intrauterine restriction in the third trimester that has an adverse effect on future adverse metabolic outcome.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:İnsülin direnci · Süt çocuğu · prematür

Abstract

Objective: Aim of this study was to evaluate insulin resistance in preterm born children born appropriate for gestational age (AGA) or small for gestational age (SGA). Material and Methods: Ninety-three preterm born children grouped as premature SGA (n=30) and premature AGA (n=63) were evaluated at age 4.6±0.2 years and 4.7±0.1 years with respect to their glucose, insulin and IGFBP-1 levels. Their data were compared to that of body mass index (BMI) matched term SGA (n=42) and term AGA (n=44) children of age 4.5±0.2 and 3.8±0.1 years. All children had height appropriate for their target height. Insulin resistance was evaluated by basal insulin and homeostasis model assessment for insulin resistance (HOMA-IR). Results: Basal insulin level was similar in preterm AGA (4.3±1.4 pmol/l) and term AGA (7.9±6.4 pmol/l) children at similar and normal BMI levels. Preterm SGA children had insulin levels (5.0±3.6 pmol/l) similar to preterm AGA children but significantly lower than that in term SGA children (23.7±20.8 pmol/l) (p=0.001). Similar results were obtained for HOMA-IR. Term SGA children also had significantly lower IGFBP-1 levels. Conclusions: Premature born AGA and SGA children do not have insulin resistance when compared to term children if they have made a catch-up growth appropriate for their target height and have normal BMI. The similar insulin levels in preterm SGA and preterm AGA children together with increased insulin levels in term SGA children points to the fact that it is the intrauterine restriction in the third trimester that has an adverse effect on future adverse metabolic outcome.

Özet

Amaç: Bu çalışmada preterm doğan ve doğum ağırlığı gestasyon yaşına göre normal (AGA) veya düşük (SGA) olan çocuklarda insülin direncinin değerlendirilmesi hedeflendi. Gereç ve Yöntem: Preterm doğan doksan üç çocuk, prematüre SGA (n=30) ve prematüre AGA (n=63) olarak gruplandı. Kronolojik yaşları sırasıyla 4.6±0.2 ve 4.7±0.1 yıl olan gruplarda glukoz, insülin ve IGFBP-1 düzeyleri değerlendirildi. Bulgular vücut kitle indeksi (VKİ) benzer, 4.5±0.2 yaşındaki term SGA (n=42) ve 3.8±0.1 yaşındaki term AGA (n=44) çocukların değerleri ile karşılaştırıldı. Tüm çocukların boyu hedef boyuna uygundu. İnsülin direnci, bazal insülin değeri ve insülin duyarlılık indeksi (HOMA-IR) ile değerlendirildi. Bulgular: Bazal insülin değeri VKİ’leri benzer olan preterm AGA (4.3±1.4 pmol/l) ve term AGA (7.9±6.4 pmol/l) çocuklarda benzerdi. Preterm SGA çocukların insülin değeri (5.0±3.6 pmol/l) preterm AGA çocuklara benzerdi, ancak term SGA çocuklardan belirgin olarak düşüktü (p=0.001). HOMA-IR sonuçları benzerdi. Term SGA çocukların IGFBP-1 düzeyleri de anlamlı olarak düşüktü. Sonuç: VKİ’leri normal ve büyümede yakalamasını yapmış, prematüre doğan AGA ve SGA çocuklarda, term doğanlar ile karşılaştırıldığında insülin direnci saptanmadı. Preterm SGA va preterm AGA çocuklarda benzer insülin değerleri saptanırken term SGA çocuklarda insülin değerlerinin artmış olarak bulunması, yaşamın ileri dönemlerinde olumsuz metabolik sonuçların ortaya çıkmasında üçüncü trimesterdeki intrauterin olumsuz etkilerin rolüne işaret etmektedir.

🔖

Cite This Article

DARENDELİLER, F. F., BAŞ, F., BUNDAK, R., ÇOBAN, E. A., BAŞ, N., SANCAKLI, Ö., ERYILMAZ, K. S., KÜÇÜKEMRE, B., DİŞÇİ, R., GÖKÇAY, G., AKI, S., İNCE, Z., ESKİYURT, N. (2008). Insulin resistance in preterm born children during prepubertal ages. Çocuk Dergisi, Cilt: 8 - Sayı: 2, 87–92. https://ajindex.com/articles/151072

References (12)

  1. Barker, DJP. The fetal origins of coronary heart disease. Acta Paediatrica Supplement, 1997; 422:78-82
  2. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, Levy-Marchal C. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia, 2005; 48:849-55
  3. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and childhood growth of persons whodevelop type 2 diabetes. Annals of Internal Medicine, 2000; 133:176-182
  4. Barker DJP, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adult. New England Journal of Medicine, 2005; 353:1802-9
  5. Eriksson JG, Forsen T, Tuomilehto J, Jaddoe VWV, Osmond C, Barker DJP. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia, 2002; 45:342-8
  6. Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales, CN, Ness AR, Dunger DB&the ALSPAC study Team. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin like growth factor-I levels. Diabetologia, 2004; 47:1064-70
  7. Veening MA, Van Weissenbruch MM, Delemarre-Van de Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. Journal of Clinical Endocrinology and Metabolism, 2002; 87:4657-61
  8. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD. Insulin resistance in short children with intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism, 1997; 82:402-6
  9. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iniquez G, Ong KK, Dunger DB, Mericq MV. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestationalage infants at age 1 year: results from a prospective cohort. Journal of Clinical Endocrinology and Metabolism, 2003; 88:3645-50
  10. Garnett S, Cowell CT, Bradford D, Lee J, Tao C, Petrauskas V, Fay R, Baur LA. Effects of gender, body composition and birth size on IGF-I in 7-and 8-year old children. Hormone Research, 1999; 52:221-9
  11. Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM&Cutfield WS. Premature birth and later insulin resistance. New England Journal of Medicine, 2004; 351:2179-86
  12. Bazaes RA, Alegria A, Pittaluga E, Avila A, Inique G&Mericq V. Determinants of insulin sensitivity and secretion in ver